Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy

被引：0
|
作者：
Faruk Tas
Senem Karabulut
Rumeysa Ciftci
Fatma Sen
Burak Sakar
Rian Disci
Derya Duranyildiz
机构：
[1] Istanbul University,Institute of Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 73卷
关键词：
LDH; CEA; CA19-9; Metastatic; Pancreatic cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1163 / 1171
页数：8
相关论文
共 50 条
  • [1] Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy
    Tas, Faruk
    Karabulut, Senem
    Ciftci, Rumeysa
    Sen, Fatma
    Sakar, Burak
    Disci, Rian
    Duranyildiz, Derya
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (06) : 1163 - 1171
  • [2] Clinical significance of serum LDH, CEA and CA19-9 levels in metastatic pancreatic cancer
    Karabulut, S.
    Ciftci, R.
    Sen, F.
    Tas, F.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S601 - S602
  • [3] Metastatic prostate cancer with elevated serum levels of CEA and CA19-9
    Juang, Guang-Dar
    Hwang, Thomas I. S.
    Wang, Yuan-Hung
    UROLOGICAL SCIENCE, 2014, 25 (01) : 28 - 30
  • [4] Prognostic value of serum carbohydrate 19-9 in patients receiving gemcitabine-based neoadjuvant therapy for pancreatic cancer
    Mody, Kabir
    Shatzel, Joseph J.
    James, Spencer L.
    Wang, Rebecca
    Colacchlo, Thomas Anthony
    Barth, Richard J.
    Zaki, Bassem I.
    Tsapakos, Michael J.
    Suriawinata, Arief A.
    Sutton, John E.
    Gordon, Stuart R.
    Gardner, Timothy B.
    Smith, Kerrington D.
    Ripple, Gregory H.
    Hourdequin, Kathryn Cunningham
    Tsongalis, Gregory J.
    McGrath, Elizabeth Boutin
    Pipas, J. Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Prognostic value of serum CEA and CA19-9 levels in pancreatic ductal adenocarcinoma
    Ermiah, Eramah
    Eddfair, Mona
    Abdulrahman, Othman
    Elfagieh, Mohamed
    Jebriel, Abdalla
    Al-Sharif, Mona
    Assidi, Mourad
    Buhmeida, Abdelbaset
    MOLECULAR AND CLINICAL ONCOLOGY, 2022, 17 (02)
  • [6] Prognostic values of serum CA19-9 and CEA levels for colorectal cancer
    Nakayama, T
    Watanabe, M
    Teramoto, T
    Kitajima, M
    ONCOLOGY REPORTS, 1997, 4 (04) : 819 - 822
  • [7] The prognostic value of preoperative serum levels of CEA and CA19-9 in patients with gastric cancer
    Kodera, Y
    Yamamura, Y
    Torii, A
    Uesaka, K
    Hirai, T
    Yasui, K
    Morimoto, T
    Kato, T
    Kito, T
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1996, 91 (01): : 49 - 53
  • [8] Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer
    Kochi M.
    Fujii M.
    Kanamori N.
    Kaiga T.
    Kawakami T.
    Aizaki K.
    Kasahara M.
    Mochizuki F.
    Kasakura Y.
    Yamagata M.
    Gastric Cancer, 2000, 3 (4) : 177 - 186
  • [9] Comorbidity, not age, is prognostic in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Sasahira, Naoki
    Tsujino, Takeshi
    Kogure, Hirofumi
    Yagioka, Hiroshi
    Yashima, Yoko
    Togawa, Osama
    Arizumi, Toshihiko
    Matsubara, Saburo
    Hirano, Kenji
    Tada, Minoru
    Omata, Masao
    Koike, Kazuhiko
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 (03) : 252 - 259
  • [10] Relationship between serum CA19-9 and CEA levels and prognosis of pancreatic cancer
    Wu, Lei
    Huang, Peijun
    Wang, Fang
    Li, Daqian
    Xie, Erfu
    Zhang, Yan
    Pan, Shiyang
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (21)
12345